Webinar | January 8, 2025

Apheresis In Cellular Therapies: Unlocking Quality For CAR T And Stem Cell Treatments

Join us for an insightful webinar that explores the crucial role of apheresis in sourcing high-quality starting material for cellular therapies. As regenerative medicine continues to advance, understanding the complexities of apheresis is more important than ever. In this session, expert presenters will walk you through the apheresis procedure, emphasizing its vital role in collecting cellular components for therapies such as CAR T-cell treatments and stem cell transplants, while addressing key considerations for donor sourcing and patient treatment.

They will also explore how apheresis-based bone marrow transplantation and donor programs can enhance hospital operations, strengthen reputations, and expand patient services. Additionally, the webinar will highlight the essential role of skilled nurses in ensuring both patient and donor safety and comfort, while underscoring how their expertise directly impacts the quality of the collected material.

Focusing on quality, the presenters will discuss the importance of adhering to collection protocols and the real-world effects on treatment outcomes. Attendees will gain insight into how small variations in the apheresis process can lead to significant differences in the cellular products, ultimately influencing therapy effectiveness. Finally, the session will cover the selection criteria for qualified practitioners and the systems in place to ensure optimal apheresis results.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises